𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind, placebo-controlled phase Ib study with selisistat (SEN0014196) in patients with Huntington's disease

✍ Scribed by Süssmuth, S.D.; Landwehrmeyer, G.B.; Tabrizi, S.J.; Andersen, C.; DiBacco, M.; Tripepi, G.; Westerberg, G.


Book ID
122822093
Publisher
Elsevier
Year
2013
Tongue
English
Weight
49 KB
Volume
3
Category
Article
ISSN
2210-5336

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES